Lab21 to Develop microRNA-Based Colorectal Cancer Diagnostic for IntegraGen
February 28, 2013
Lab21 to Develop microRNA-Based Colorectal Cancer Diagnostic for IntegraGen
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Lab21, IntegraGen to Develop PCR-Based Assay to Guide Colorectal Cancer Therapy
February 28, 2013 / PCR Insider - Lab21, IntegraGen Co-developing CDx for Colorectal Cancer Therapy
February 22, 2013 / GenomeWeb Daily News - Exiqon Releases Data on Blood-Based Colorectal Cancer Test
October 27, 2011 / Gene Silencing News - France's Theradiag Buys microRNA Diagnostics Shop Prestizia
June 28, 2012 / Gene Silencing News - Marina Aims for Industry Partnership in 2012, Posts Lower Q3 Losses
November 10, 2011 / Gene Silencing News